Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It" ALT"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who…
Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017)
Life Sciences Jobs ... Source: BioSpace
Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free" ALT"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple…
Belcher Pharma Petitions FDA to Alter Epinephrine Warning Label
Belcher Pharmaceuticals petitioned the FDA to amend its warning requirements for epinephrine injectables containing sulfites. Source: Drug Industry Daily
Express Scripts Claims ‘Profiteering’ in Suit against Overdose Treatment Manufacturer
The nation’s largest pharmacy benefits manager, Express Scripts, has sued Kaleo — maker of Evzio, an injectable emergency treatment for heroin and painkiller overdoses — claiming it owes nearly $15…
Pfizer Launches Its Own Challenge to Genentech’s Herceptin Patent, Following Celltrion, Mylan
Following two other firms, Pfizer filed its own petitions with the PTO over a Herceptin patent owned by Genentech, as it continues to develop its biosimilar. Source: Drug Industry Daily
DOJ to Review ‘Slap on the Wrist’ Enforcement of Opioid Manufacturers, Distributors
The Department of Justice announced plans to review the Drug Enforcement Administration’s efforts to combat the spread of illegal opioid use through the agency’s enforcement actions against industry companies. Source:…
Cleanroom Problems Found in California Pharmacy Inspection
FDA inspectors found extensive cleanliness and sterility issues during visits to California Pharmacy and Compounding Center in Newport Beach, Calif., in March and April. Source: Drug Industry Daily